Genetics Companies End Patent Dispute Over HPV Test

Law360, New York (January 13, 2006, 12:00 AM EST) -- Two feuding genetic testing product companies have ended a patent dispute over testing methods used to detect risk for the human papilloma virus, a common sexually transmitted infection that causes cervical cancer.

The settlement agreement comes about three months after Third Wave Technologies Inc. sued the Maryland-based Digene Corporation, seeking declaratory judgment supporting Third Wave's right to sell its HPV products.

In a press release on Friday, Digene stated that Third Wave had dismissed the suit without prejudice. Representatives from both companies could not be reached...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.